Kirti Singh, PhD

Kirti Singh earned her PhD in molecular pharmacology from Dr. Moniri’s lab at Mercer University, Atlanta, Georgia, USA. After graduating she worked at Eli Lilly as a postdoctoral scholar in early phase preclinical drug development for novel target identification and characterization in pulmonary fibrosis. She joined Viswanath lab in November 2024 as a postdoc, with the focus to investigate brain tumor metabolism in preclinical models to advance metabolic imaging and therapy. Apart from lab, she enjoys cooking, hiking, and exploring national parks.